| 12.74 -0.19 (-1.47%) | 04-24 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 16.22 | 1-year : | 17.37 |
| Resists | First : | 13.89 | Second : | 14.88 |
| Pivot price | 13.25  |
|||
| Supports | First : | 12.28 | Second : | 10.22 |
| MAs | MA(5) : | 12.66  |
MA(20) : | 13.36 |
| MA(100) : | 14.31 |
MA(250) : | 14.32 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 23.5 |
D(3) : | 18.6 |
| RSI | RSI(14): 40.8 |
|||
| 52-week | High : | 19.13 | Low : | 8.65 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ATEC ] has closed above bottom band by 28.7%. Bollinger Bands are 5.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 13.09 - 13.15 | 13.15 - 13.21 |
| Low: | 12.39 - 12.46 | 12.46 - 12.51 |
| Close: | 12.63 - 12.75 | 12.75 - 12.84 |
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
Tue, 23 Apr 2024
When Should You Buy Alphatec Holdings, Inc. (NASDAQ:ATEC)? - Yahoo Finance
Tue, 23 Apr 2024
Alphatec Holdings, Inc. (NASDAQ:ATEC) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Mon, 22 Apr 2024
Would Alphatec Holdings (NASDAQ:ATEC) Be Better Off With Less Debt? - Simply Wall St
Wed, 17 Apr 2024
ATEC to Report First Quarter Financial Results on May 7, 2024 - Business Wire
Sun, 31 Mar 2024
Alphatec Holdings, Inc. (NASDAQ:ATEC) Screens Well But There Might Be A Catch - Simply Wall St
Tue, 27 Feb 2024
Alphatec Holdings Inc (ATEC) Reports Robust Revenue Growth and Margin Expansion in FY 2023 - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 138 (M) |
| Shares Float | 98 (M) |
| Held by Insiders | 34.7 (%) |
| Held by Institutions | 67.4 (%) |
| Shares Short | 12,360 (K) |
| Shares Short P.Month | 11,300 (K) |
| EPS | -1.54 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.56 |
| Profit Margin | -38.8 % |
| Operating Margin | -25.4 % |
| Return on Assets (ttm) | -14 % |
| Return on Equity (ttm) | -411.8 % |
| Qtrly Rev. Growth | 30.2 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 3.49 |
| EBITDA (p.s.) | -0.67 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -78 (M) |
| Levered Free Cash Flow | -73 (M) |
| PE Ratio | -8.28 |
| PEG Ratio | -1 |
| Price to Book value | 22.75 |
| Price to Sales | 3.64 |
| Price to Cash Flow | -22.4 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|